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Introduction
One of the strategies for gene therapy of cancer employs so-called 'suicide' genes. 1 The most widely studied system involves the transfer of the herpes simplex thymidine kinase (hTK) gene into tumor cells, followed by exposure to ganciclovir (GCV). 2 GCV is phosphorylated to GCV monophosphate (GCV-MP) by hTK, and then further phosphorylated to GCV diphosphate (GCV-DP) and GCV triphosphate (GCV-TP) by normal cellular kinases. GCV-TP competes with deoxyguanosine triphosphate for DNA polymerase. 3 As a result, DNA synthesis is impaired which may result in tumor cell death.
It was observed that not only the cells expressing the hTK gene were killed by exposure to GCV but also unmodified neighboring tumor cells, 4 a feature termed the 'bystander effect' (BSE). 5 An amplifying mechanism such as the BSE is absolutely essential for success of the hTK system because there are no techniques available which are efficient enough to transduce all the cancer cells or even those contained within a local deposit of cancer.
The earliest in vitro exploration of the BSE demonstrated the necessity for close physical contact between cells for the BSE to be observed. It was speculated that this permitted transport of active GCV metabolites from hTK cells to neighboring unmodified cells. The most likely mechanism for such transfer was via channels of metabolic cooperation, gap junctions, which are known to permit cell-to-cell exchange of ions and certain other small molecules. Although not universally accepted, 6 several investigators have presented evidence supporting this view. [7] [8] [9] [10] [11] [12] [13] To address this issue in greater detail, we evaluated a large panel of tumor cell lines for their sensitivity to the BSE and for the relationship between the BSE and the function of gap junctions in those tumor cells.
Results
The BSE in vitro in various cell lines As a rapid and reproducible in vitro assay for the BSE, we previously reported a technique measuring 3 Hthymidine incorporation in mixed tumor cell cultures consisting of various ratios of wild-type and hTK genemodified tumor cells exposed to various concentrations of GCV.
14 The BSE is present if the inhibition of 3 Hthymidine incorporation in the mixed tumor cultures exposed to GCV is greater than the inhibition expected based on the proportion of hTK-expressing cells in the tumor mixture. Using this assay, tumor cells with widely differing intrinsic sensitivities to the BSE were identified including several tumors that appeared to be nearly completely resistant to this effect. As confirmation, tumor cells identified as being BSE-resistant in vitro were also shown to be resistant to the BSE in GCV-treated animals bearing subcutaneous tumors containing mixtures of wild-type and hTK gene-modified tumor cells. Figure 1 illustrates the results of this in vitro assay of the BSE in four different tumor lines. The rat 9L gliosarcoma is highly sensitive to the BSE with mixtures containing only 10% hTK-expressing cells inhibited as much as the cultures consisting of 100% hTK-9L cells. By con-
Figure 1 Variability of the BSE from cell line to cell line. Mixtures of hTK-expressing and wild-type cells were tested in a proliferation assay in vitro for evidence of a BSE. The proportion of cells expressing hTK in the mixtures (0, -᭜-; 10, -̆-; 50, -ᮀ-; and 100%, -᭹-) is indicated. The cell mixtures were exposed to various concentrations of GCV ranging from 0.5 to 50 m and its inhibitory effect calculated as a proliferation fraction. Proliferation fraction is the ratio of 3 H-thymidine incorporation for the cell mixture exposed to GCV versus mixtures not exposed to GCV. These various cell lines represent examples of cells with no BSE (Neuro2a), low BSE (MesII25), medium BSE (MCA 38) and high BSE (9L).
trast, the murine neuroblastoma tumor line Neuro2a is apparently completely resistant to the BSE with 3 Hthymidine incorporation inhibited only in direct proportion to the percentage of hTK-expressing cells contained in the cultured tumor cell mixture. Table 1 contains a list grading the responses of 17 different tumors in this in vitro assay of the BSE and identifies five tumor lines that appear to be BSE negative including Neuro2a, L929, K562, S49, J774. It is important to note that resistance to the BSE does not indicate intrinsic resistance to killing by hTK/GCV since in each case cell growth in the cultures containing 100% hTK gene-modified cells were inhibited upon GCV exposure, although there are differences between the various tumors in the optimal concentration of GCV required for complete inhibition (Figure 1 ). 
The average BSE index (BSEi) for each cell line, from at least three separate experiments is shown in parentheses. We have arbitrarily divided the cell lines into four groups according to their relative BSE index score.
Calcein transfer assay/flow cytometry Since previous work had suggested that the BSE might be due to cell-to-cell transfer of phosphorylated GCV metabolites via metabolic coupling through gap junctions, we measured gap junction function in various tumor cell lines using flow cytometry. This assay employs one tumor cell population labeled with a stable fluorescent dye integrated into the cell membrane (DiI) and another tumor cell population preloaded with a small molecular weight fluorescent dye (calcein acetoxymethyl ester; calcein AM, Molecular Probes, Eugene, OR, USA). After co-culture of these two labeled tumor cell populations, detection of double labeled cells by flow cytometry indicates transfer of the calcein dye from the original cell into a DiI-labeled cell, an indication of gap junction function. Figure 2 also illustrates the dramatic dye transfer seen in the 9L tumor line and further demonstrates that maximum calcein intensity in the target cells occurred within 3 h of co-culture. The kinetics of dye transfer varies quite widely between different tumor lines, with maximal transfer at different time-points. Table 2 shows that dye transfer can be measured in heterologous mixtures containing tumor cells from different species, in this case dye transfer occurred in each direction in mixtures of cells derived from a murine adenocarcinoma and a human hepatoma. Unfortunately the measured dye transfer value is dependent upon several variables, such as different kinetics in the different tumor populations, which make standardization of the assay difficult. However, even though the relative degree of dye transfer at one timepoint cannot be directly compared from tumor to tumor as an indication of the level of gap junction function, Table 3 shows that among the 17 tumor lines tested, the same five tumor lines that did not show a BSE in vitro in the inhibition of proliferation assay (Table 1) , also showed no evidence of dye transfer. Thus, the absence of a BSE in vitro correlates completely with the absence of dye transfer and therefore presumably with the absence of gap junction communication.
Figure 2 Kinetics of calcein transfer. Single parameter (log calcein fluorescence intensity) histogram analysis of DiI-stained 9L cells co-cultured with calcein-stained 9L cells. 0.4 × 10 6 cells per well (six-well plates) with 50% DiI cells and 50% calcein cells were co-cultured. DiI cells containing transferred calcein were analyzed by FACS at various time-points during co-culture. The values in parentheses indicate the percentage of cells with calcein fluorescence above the threshold intensity found in cells at 0 h (the 1% of green fluorescence positive cells at 0 h is due to background fluorescence).
Modulation of gap junctional communication With this correlation, we then tested an agent which had previously been shown to interfere with gap junction function. 9L cells were incubated with dieldrin (Sigma, St Louis, MO, USA), an organophosphate insecticide, during the 6 h of dye transfer co-culture and the cells were then assayed by flow cytometry. Dieldrin exposure Figure 3 , dieldrin nearly completely abolished the BSE, but importantly, did not block GCVmediated killing of the hTK-modified 9L tumor cells in these cultures. Again, the correlation between gap junction function and the BSE effect was confirmed. Finally, we tested forskolin (Sigma) in these assays with the hope that such treatment would up-regulate gap junction function and therefore increase the BSE. The addition of forskolin to the co-cultures during the period of dye transfer resulted in a 20% augmentation of gap junction coupling in C3H10T cells (not shown). However, when forskolin was added to co-cultures of C3H10T cells to test its effect on the BSE, it did not increase the antiproliferative effect of GCV as hoped. In fact, high doses of forskolin even reduced the effect of GCV on 100% hTKmodified tumor cells (Table 4) . Thus, although forskolin did increase gap junction communication, it also unexpectedly directly inhibited the cytotoxic activity of hTK/GCV and therefore its potential effect on the BSE could not be measured.
Discussion
To be effective, treatments for cancer need to eliminate or control all the malignant cells in a patient. Similarly, for gene therapy strategies to be effective in cancer treatment they must either directly modify and kill all the cancer cells or function via another property which results in broad control of the malignant cells. Surprisingly, some strategies for direct gene modification of cancer have resulted in elimination of a much larger fraction of tumor 100% hTK-expressing C3H10T cells were exposed to 30 m forskolin for 16 h and then fresh medium with the same concentration of forskolin, with or without GCV (5 m) was added. After 13 h, the cells were exposed to 3 H-thymidine incorporation for 10 h. Growth inhibition was calculated as the ratio of the proliferation measured in GCV exposed cells per proliferation of cells not exposed to GCV. cells than could be accounted for by the fraction actually expressing the transgene, a phenomenon termed the bystander effect (BSE). The present study has focused on the role that metabolic cooperation plays in the BSE seen in association with the HSVtk/GCV system of cancer gene therapy. Other factors thought to play a role in such a BSE include induction of an immune response against the tumor cells [15] [16] [17] and/or an anti-tumor effect resulting from ischemia caused by either direct gene modification or other secondary effects on the tumor vascular endothelial cells. 18 A 'distant' BSE has also been observed in immunodeficient mice, 19 suggesting another systemic, but non-immune anti-tumor bystander killing mechanism. Development of a clearer understanding of the various mechanisms which result in an amplification of these anti-tumor effects is essential to rational improvement in the therapeutic efficacy of these approaches.
One of the earliest postulated explanations for the HSVtk BSE 4 suggested transfer of phosphorylated GCV metabolites from hTK-expressing cells to neighboring wild-type cells via the gap junctional pathway (see Beyer, 20 for review on gap junctions). In essence this phenomenon seemed to be similar to the metabolic cooperation ('kiss of death', 'kiss of life') that led to the discovery of the gap junctions more than two decades ago. 21 We initially analyzed gap junctional communication in a variety of cell lines and compared this activity with the level of the BSE in these same cells. Several methods have been described to test cell-to-cell communication, usually employing electrical coupling or dye transfer assays. Dye transfer has been measured after microinjection or scrape loading of a small molecular weight dye like lucifer yellow, 22 or by fluorescence redistribution after photobleaching (FRAP). 23 Each of these methods is complex and not readily adapted to addressing our questions on mechanism. For example, in preliminary studies we found that some tumor cell lines having a definite hTK-BSE did not show any dye transfer using scrape loading/dye transfer analysis or FRAP (results not shown) and false negatives in these assays have been described by others. 24 A different assay of dye transfer proved to be more useful for analysis of the relationship between metabolic cooperation and the BSE. [25] [26] [27] Calcein AM, a small molecular weight compound, is able to freely diffuse into cells where it is enzymatically cleaved by endogenous cellular esterases to the green fluorescent compound calcein. Calcein itself cannot diffuse through the cytoplasmic membrane, but is able to traverse through gap junctions. 25 DiI, a lipophylic red fluorescent dye, is stably incorporated into the cell membranes and is not metabolized or exchanged with neighboring cells. 28 In this assay of gap junctional activity, mixtures of receiving 'bystander' cells stained with DiI and 'donating' cells stained with calcein AM are analyzed at various timepoints by flow cytometry and the proportion of red 'bystander' cells found also to contain 'donated' green fluorescence from calcein are calculated as a measure of dye transfer via gap junctions.
This method has been reported to be useful for the study of gap junctional communication and our own preliminary tests confirmed that no calcein transfer occurred across an artificial membrane, there was no passive capture of the dye after killing the calcein donating-cells by repeated freeze-thaw cycles, and that the amount of dye transfer was a function of cell density and the percentage of donating cells (data not shown). Although potentially more quantitative and sensitive than other methods using dye transfer to study gap junction function, this procedure was not without its own limitations. Among these, there were unexplained differences in calcein transfer kinetics seen from cell line to cell line. There also was not a close correlation between the calcein transfer value (or the percentage of coupled cells) and the intensity of the BSE (Table 3 ). This may result because calcein and phosphorylated-GCV differ in their electrical and physical properties as well as their metabolic features. Molecular weight did not seem to be a critical factor because in several cell lines we observed a transfer of phosphorylated GCV (MW 333, 412 and 491 for GCV-MP, GCV-DP and GCV-TP, respectively) and calcein (MW 623), but not lucifer yellow (MW 443) or carboxyfluorescein (MW 376) (data not shown). The specific connexin protein forming the gap junction channel can play a role by modulating the transfer kinetics of calcein or GCV metabolites. Furthermore, the calcein transfer assay is very sensitive, a limited variation in donating cells ends up with a larger variation in CTV or percentage of coupled cells. Finally, the differing sensitivity of the various cell lines to phosphorylated-GCV (evaluated by the anti-proliferative effect of GCV on TK-expressing cells) may represent the principal factor to the absence of quantitative correlation. For instance, MesII20 and 9L had the same CTV, but MesII20 had a sensitivity to phosphorylated-GCV half that of 9L. Similarly, the BSEi of MCA38, SKHep1 and MesII25 correlated with their respective sensitivity to phosphorylated-GCV. UMR106 has a high BSEi in spite of a low CTV because of its extreme sensitivity to phosphorylated-GCV. Conversely, C6 has a low BSEi in spite of a good sensitivity to GCV because of a low CTV. Therefore, BSE can be approximately predicted by measuring both GCV sensitivity and CTV.
Despite these limitations, as a qualitative assay the determination of calcein transfer correlated perfectly with our functional assessment of the BSE in all of the 17 cell lines tested, ie cells lacking BSE also lacked dye transfer and cells with a detectable BSE did show dye transfer in this assay.
Fick and colleagues 9 have also employed this type of assay to study the correlation between the BSE and calcein transfer using different experimental conditions which employed the murine fibroblast line PA317 as the calcein donating hTK + cell in heterocellular coupling with nine different rodent or human tumor cell lines. In contrast to our observations studying dye transfer between cells of the same tumor, their studies showed a more quantitative relationship between dye transfer and BSE activity, although they did not study any cell lines actually lacking a BSE. Heterocellular coupling reactions may be prone to additional sources of variability as illustrated in Table 2 in which the degree of calcein transfer observed between the murine tumor MCA38 and the human tumor Hep1 varied considerably depending on which cell was the donor and which the recipient.
The influence of pharmacologic agents known to regulate the expression of gap junctions was then tested to determine whether they would show coordinate effects on both dye transfer and the BSE. Drugs known to function as gap junction down-regulators, such as the organophosphate insecticide dieldrin, 29 decreased both calcein transfer and the BSE. HSVtk/GCV-mediated killing itself was not affected since the decrease of proliferation in hTK + cells due to GCV was identical with or without dieldrin (see Figure 3 ) and GCV phosphorylation in hTK cells is not modified by addition of dieldrin (data not shown).
CAMP elevating agents, like forskolin, have been described to function as gap junction up-regulators, 30 and indeed, we observed an increase in calcein transfer/ FACS in the gap junction-competent cell lines we tested. Surprisingly however, forskolin did not increase the BSE but rather enhanced tumor proliferation (Table 4) , because it inhibited GCV toxicity in the hTK + cells. In future experiments we will have to determine if this effect is forskolin-specific or due to cAMP elevation.
Our present work and previous data 14 extend the observations of others 7, [9] [10] [11] [12] [13] supporting the role of gap junctions as the pathway for spread of phosphorylated GCV in the BSE. Gap junctional communication plays a role in the BSE, not only in vitro but also in vivo since subcutaneous tumors using a gap junction deficient cell line Neuro2a, did not show any BSE. 12 Because this HSVtk suicide gene therapy is unlikely to be effective in patients whose tumors lack gap junctions, the development of a rapid and clinically applicable assay to test for BSE function in tumors could be extremely useful in guiding patient selection for this treatment strategy. Further work on the calcein dye transfer assay may be able to validate its predictive value in actual clinical samples.
Materials and methods

Cells
The following tumor cell lines were studied: 9L (rat glioma), a gift of Dr E Oldfield (NINDS/NIH, Bethesda, MD, USA); MCA38 (mouse colon adenocarcinoma) and A375 (human melanoma), gifts of Dr S Rosenberg (NCI/NIH, Bethesda, MD, USA); UMR106 (rat osteosarcoma), C3H10T1/2 cl8 (mouse embryo fibroblast), C6 (rat glioma), SK-Hep1 (human liver adenocarcinoma), L929 (mouse fibroblast), Neuro2a (mouse neuroblastoma), J774 (mouse macrophage), S49.1 (mouse lymphoma), K562 (human erythroleukemia) purchased from ATCC (Rockville, MD, USA); MesII25 and MesII20 (rat mesotheliomas) gifts from Dr J Craighead (University of Vermont, Colchester, VT, USA); DND and JMN (human mesotheliomas) gifts from Dr B Gerwin (NCI/NIH, Bethesda, MD, USA). All cell lines were grown in R10 medium (RPMI with 10% FCS except the two rat mesothelioma cell lines (MesII20 and MesII25), which were grown in M10 medium: (DMEM+F12: 1+1, with 10% FCS and supplemented with transferrin: 2.5 g/ml, hydrocortisone: 0.1 g/ml, selenium: 2.5 ng/ml, insulin: 2.5 g/ml). The SK-Hep1 cell line was grown in R10 with 1 mm sodium pyruvate. All cultures were grown in a 37°C incubator with 5% CO 2 .
Retroviral vectors
The original STK vector (packaged in the ecotropic cell line psi-2) was used to transinfect PA317 and PG13 vector packaging cell lines. After G418 selection, supernatant from these lines containing, respectively, amphotropic and xenotropic STK vector particles was collected.
All tumor cell lines except for the two human mesotheliomas (JMN, DND) were transduced to express the hTK gene stably after transduction/G418 selection with STK retrovirus supernatant produced in PA317. No G418 resistant colonies were obtained from these two mesothelioma cell lines in a series of three experiments. However, hTK-expressing mesothelioma cells were readily obtained by using the STK vector packaged with the gibbon ape leukemia virus envelope produced in the PG13 packaging cell line.
In vitro BSE assay GCV (Syntex, Palo Alto, CA, USA) effect and in vitro BSE were measured using a 3 H-thymidine incorporation assay as previously described.
14 Cell proliferation fraction (pf) was calculated by dividing the average c.p.m. of the GCV-exposed cell mixture by the average c.p.m. of the same tumor cell mixture not exposed to GCV. As a rough index to permit comparisons, a bystander effect index .
For experiments with gap junction down-regulators the same conditions were used except that, after a 90-min exposure to dieldrin alone, GCV was added for 2 h and 3 H-thymidine incorporation was for only 1 h. Dieldrin (Sigma) was dissolved in DMSO to not exceed 1% and control cultures were also exposed to 1% DMSO.
In experiments with forskolin, cells in 96-well plates were exposed during the first 16 h to 30 m forskolin (Sigma), then fresh medium with the same concentration of forskolin, with or without GCV was added for 13 h, followed by 3 H-thymidine incorporation for 10 h.
Dye transfer assay by flow cytometry Cells were harvested, counted and then divided into two aliquots that were stained with either DiI (1,1′ dioctadecyl 3,3,3′,3′ tetramethylindocarbocyanine perchlorate; Molecular Probes) at 2.5 or 5 g/ml or with calcein AM (Molecular Probes) at 0.1 or 0.2 m. The staining was done in complete medium for 20 min at 37°C in 14 ml conical tubes on a rotating device. The cells were rinsed with HBSS, then with complete medium and put back at 37°C on a rotating device for 50 min. The cells were rinsed in HBSS and then resuspended in complete medium. Mixtures of stained cells containing 90% DiI cells and 10% calcein AM cells were plated in six-well plates at 0.4 × 10 6 cells per well. After 6 h the mixed cultures were harvested and resuspended in HBSS for flow cytometry analysis (FACScan; Becton Dickinson, Franklin Lakes, NJ, USA). For the control, DiI and calcein AM cells were incubated separately and only mixed just before FACS analysis. Dead cells were excluded by forward light scatter.
The calcein transfer value (CTV) was determined as the ratio of the mean calcein fluorescence intensity (Xmean) of the DiI population co-cultured for 6 h with calcein donating cells divided by the mean calcein fluorescence intensity of the control DiI cells mixed with calcein cells just before the FACS assay. Values above 1 indicate that calcein dye transfer had occurred during the co-culture period.
